Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

Lobo’s Big Bets Deliver in Stryker’s 1st Billion $ Recon Quarter

Image created by RRY Publications, LLC / Source: Pixabay and PDPics
Image created by RRY Publications, LLC / Source: Pixabay and PDPics

Kevin Lobo, Stryker’s CEO and his Lieutenant, Katherine Owen, outperformed Wall Street’s expectations and hit a $1 billion quarterly milestone. With smaller acquisitions and a big get on robots and ankles, the company is laying the foundation for a notably bright future. Read what they told analysts.

Do Sunshine Act Disclosures Hurt Ortho Innovation? // “Holy Grail” of Registries Ramping Up // and More!

Source: Pixabay and Nemo
Source: Pixabay and Nemo

Brian Cole, M.D. and colleagues are doing their best to clarify the misunderstandings surrounding the Sunshine Act. The largest-ever consortium of orthopedic registries is proving to be different and very valuable. And the Vice President of Research at Merck details the company’s latest efforts to find a drug for osteoporosis.

Advertisement
Advertisement

Lee Debates Barrack: Ceramic-Ceramic THA

Image created by RRY Publications, LLC
Image created by RRY Publications, LLC

“Ceramic-ceramic hips have a place in young, active patients,” advocates Gwo-Chin Lee. “And they have the lowest wear rate.” Robert Barrack counters, “The new ceramics are better, but standard metal-crosslinked poly has improved more. And the 10-15 year results cannot be improved upon. Ceramic-ceramic isn’t ready for prime time.”

Myths and Facts About Orthopedic Surgeon Compensation

Source: Wikimedia Commons and Kobac
Source: Wikimedia Commons and Kobac

Two announcements regarding orthopedic surgeon compensation—one on the last day of September and one a month earlier—offer startling new information about surgeon pay and how ineffective it is at delivering job satisfaction or even performance. For regulators, this article has a few inconvenient truths.

Advertisement

MRI From Your Smartphone? Auto Billing When You Step Out of the Exam Room? Yes! // New HSS Study to Tackle Critical ACL, UCL Failure Issue // and More!

EMA Orthopedics Smartphone App / Courtesy: Modernizing Medicine
EMA Orthopedics Smartphone App / Courtesy: Modernizing Medicine

“Failure is the dirty underwear drawer of orthopedic surgeons,” says David Altchek, M.D. of HSS. So his study at HSS will tackle a crucial ACL, UCL failure issue. Time and motion study for scoliosis surgery? The results from Beth Israel are fascinating. New smartphone app gives surgeons increased flexibility while also saving time.

Advertisement